Literature DB >> 10657335

Recent advances: recent advances in intensive care.

S Stott1.   

Abstract

Mesh：

Year:  2000        PMID： 10657335      PMCID： PMC1127145          DOI： 10.1136/bmj.320.7231.358

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  37 in total

1.  The pulmonary artery catheter takes a great fall.

Authors:  J D Sandham; R D Hull; R F Brant
Journal:  Crit Care Med       Date:  1998-07       Impact factor: 7.598

2.  UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs. American-European Consensus Conference on ALI/ARDS.

Authors:  B H Cuthbertson; P Dellinger; O J Dyar; T E Evans; T Higenbottam; R Latimer; D Payen; S A Stott; N R Webster; J D Young
Journal:  Intensive Care Med       Date:  1997-12       Impact factor: 17.440

3.  Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome.

Authors:  M B Amato; C S Barbas; D M Medeiros; R B Magaldi; G P Schettino; G Lorenzi-Filho; R A Kairalla; D Deheinzelin; C Munoz; R Oliveira; T Y Takagaki; C R Carvalho
Journal:  N Engl J Med       Date:  1998-02-05       Impact factor: 91.245

4.  Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition.

Authors:  R D Griffiths; C Jones; T E Palmer
Journal:  Nutrition       Date:  1997-04       Impact factor: 4.008

5.  Respective and combined effects of prone position and inhaled nitric oxide in patients with acute respiratory distress syndrome.

Authors:  L Papazian; F Bregeon; F Gaillat; X Thirion; M Gainnier; R Gregoire; P Saux; F Gouin; Y Jammes; J P Auffray
Journal:  Am J Respir Crit Care Med       Date:  1998-02       Impact factor: 21.405

6.  Improved oxygenation using the prone position in patients with ARDS.

Authors:  H Flaatten; S Aardal; O Hevrøy
Journal:  Acta Anaesthesiol Scand       Date:  1998-03       Impact factor: 2.105

7.  Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. Pressure- and Volume-Limited Ventilation Strategy Group.

Authors:  T E Stewart; M O Meade; D J Cook; J T Granton; R V Hodder; S E Lapinsky; C D Mazer; R F McLean; T S Rogovein; B D Schouten; T R Todd; A S Slutsky
Journal:  N Engl J Med       Date:  1998-02-05       Impact factor: 91.245

8.  Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group.

Authors:  R P Dellinger; J L Zimmerman; R W Taylor; R C Straube; D L Hauser; G J Criner; K Davis; T M Hyers; P Papadakos
Journal:  Crit Care Med       Date:  1998-01       Impact factor: 7.598

9.  A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill. Guy's Hospital Intensive Care Group.

Authors:  S Atkinson; E Sieffert; D Bihari
Journal:  Crit Care Med       Date:  1998-07       Impact factor: 7.598

10.  Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial.

Authors:  G U Meduri; A S Headley; E Golden; S J Carson; R A Umberger; T Kelso; E A Tolley
Journal:  JAMA       Date:  1998-07-08       Impact factor: 56.272
View more
  3 in total

1.  Recent advances in intensive care. Percutaneous tracheostomy may not be more effective than open technique.

Authors:  N Brookes; D Howard
Journal:  BMJ       Date:  2000-06-17

2.  Infections caused by multidrug resistant organisms are not associated with overall, all-cause mortality in the surgical intensive care unit: the 20,000 foot view.

Authors:  Laura H Rosenberger; Damien J LaPar; Robert G Sawyer
Journal:  J Am Coll Surg       Date:  2012-03-13       Impact factor: 6.113

3.  Postoperative Prolonged Mechanical Ventilation in Patients With Newly Diagnosed Glioblastoma-An Unrecognized Prognostic Factor.

Authors:  Patrick Schuss; Felix Lehmann; Niklas Schäfer; Christian Bode; Elisa Scharnböck; Christina Schaub; Muriel Heimann; Anna-Laura Potthoff; Johannes Weller; Erdem Güresir; Christian Putensen; Hartmut Vatter; Ulrich Herrlinger; Matthias Schneider
Journal:  Front Oncol       Date:  2020-12-18       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.